Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Galmed Pharmaceuticals Ltd. (GLMD)

8.58   0.08 (0.94%) 03-25 13:53
Open: 8.46 Pre. Close: 8.5
High: 8.82 Low: 8.41
Volume: 54,627 Market Cap: 181M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.043 - 9.089 9.089 - 9.126
Low: 8.32 - 8.366 8.366 - 8.403
Close: 8.433 - 8.505 8.505 - 8.564

Technical analysis

as of: 2019-03-25 1:30:15 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 10.94     One year: 12.78
Support: Support1: 7.92    Support2: 7.02
Resistance: Resistance1: 9.37    Resistance2: 10.94
Pivot: 8.31
Moving Average: MA(5): 8.78     MA(20): 8.35
MA(100): 8.33     MA(250): 9.69
MACD: MACD(12,26): 0.23     Signal(9): 0.17
Stochastic oscillator: %K(14,3): 69.37     %D(3): 77.09
RSI: RSI(14): 56.52
52-week: High: 27.06  Low: 4.84  Change(%): 49.0
Average Vol(K): 3-Month: 11611  10-Days: 17200

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
GLMD has closed below upper band by 27.3%. Bollinger Bands are 19.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 13 Mar 2019 14:13:37 Z
Galmed Pharmaceuticals (GLMD) Reports Q4 Loss, Misses Revenue Estimates

Tue, 12 Mar 2019 20:16:56 Z
Pre-Market Earnings Report for March 13, 2019 : NRE, VRA, DQ, EXPR, ESTE, GLMD, TRVN, GECC, SKIS, AAC, CBK

Fri, 28 Dec 2018 23:37:12 Z
Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018

Tue, 11 Dec 2018 16:41:03 Z
Novan Announces Top-Line Data From Mid-Stage Molluscum Study

Tue, 20 Nov 2018 15:11:19 Z
Galmed Pharmaceuticals (GLMD) in Focus: Stock Moves 6.2% Higher

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 21.11
Shares Float (M) 21.11
% Held by Insiders
% Held by Institutions 38.40
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.580
EPS Est. Current Year -0.940
EPS Est. Next Year -0.960
EPS Est. Next Quarter -0.250
Forward EPS -0.990
Book Value (p.s.) 2.180
PEG Ratio
Profit Margin
Operating Margin -525.76
Return on Assets (ttm) -17.9
Return on Equity (ttm) -19.0
Qtrly Rev. Growth -100.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -9.02
Levered Free Cash Flow (M) -5.82

Stock Valuations

P/E -15.05
P/E Growth Ratio 0.03
P/BV 4.00
P/S 1675366272.00
P/CF -20.43

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.